Wound News and Research

RSS

$Scientists use TPF-SHG microscopy to study effects of micro-ablative fractional laser resurfacing$

Scientists use TPF-SHG microscopy to study effects of micro-ablative fractional laser resurfacing

Many people in the Western World consider it as a social need to hide the effects of aging. For this purpose, different cutaneous rejuvenation treatments have been developed, including a laser-based technique, known as laser resurfacing.

20 Nov 2014

Platelet-like nanoparticles mimic human body's coagulation process

Stanching the free flow of blood from an injury remains a holy grail of clinical medicine. Controlling blood flow is a primary concern and first line of defense for patients and medical staff in many situations, from traumatic injury to illness to surgery.

13 Nov 2014

University of Melbourne researcher explores impact of living with chronic wounds

People who live with chronic wounds are often disadvantaged financially and emotionally and remain a hidden aspect of our healthcare system.

12 Nov 2014

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

Stradis Healthcare signs definitive agreement to acquire Medikmark

Stradis Healthcare is pleased to announce that it has entered into a definitive acquisition agreement with Medikmark, a leading provider of healthcare kits based in Waukegan, IL, under which Stradis will acquire all shares of Medikmark.

7 Nov 2014

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field.

7 Nov 2014

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Gentiva Health Services, Inc., one of the largest providers of home health, hospice and community care services in the United States, today reported net revenues of $498.0 million, adjusted EBITDA of $48.5 million and adjusted income attributable to Gentiva shareholders per diluted share of $0.28.

5 Nov 2014

Rice-led research shows how migratory cancer cells acquire 'stem-like' properties

In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic. The research reveals a common pattern in the decision-making that allows cancer cells to both migrate and form new tumors. Researchers say the commonality may open the door to new drugs that interfere with the genetic switches that cancer must flip to form both cancer stem cells and circulating tumor cells -- two of the main players in cancer metastasis.

31 Oct 2014

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Though therapies are in their nascent phase, sales of stem cell technologies are expected to show an annual increase of 16.2% over the 2010-2020 period, reaching an expected market value of nearly $1 billion, according to Kalorama Information's report, Stem Cell Therapeutics Markets.

31 Oct 2014

Two major studies newly implicate dozens of genes in autism

Two major genetic studies of autism, led in part by UC San Francisco scientists and involving more than 50 laboratories worldwide, have newly implicated dozens of genes in the disorder. The research shows that rare mutations in these genes affect communication networks in the brain and compromise fundamental biological mechanisms that govern whether, when, and how genes are activated overall.

31 Oct 2014

Surgeons fine-tune imaging techniques to enhance visualization of breast tumors, persistent wounds

Surgeons are tweaking existing computer technologies to enhance their visualization of cancerous tumors and persistent wounds according to two studies presented this week at the 2014 American College of Surgeons Clinical Congress.

31 Oct 2014

MiMedx Group revenue up 108% in third quarter 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its results for the third quarter ended September 30, 2014.

30 Oct 2014

Robotically assisted CABG surgery reduces complications, cuts recovery times

Robotically assisted coronary artery bypass grafting (CABG) surgery is a rapidly evolving technology that shortens hospital stays and reduces the need for blood products, while decreasing recovery times, making the procedure safer and less risky, says a study presented at the Canadian Cardiovascular Congress.

29 Oct 2014

AHI develops TRUHEAL Wound Program for diabetics

After nine years of research and development, Advanced Health Institute, a medical startup company, has developed a process that is changing lives called the TRUHEAL Wound Program. Because of the high success rate, major insurers pay AHI based on results of treatments, a revolutionary approach to traditional healthcare.

27 Oct 2014

Ludwig researchers discover key mechanism that control plasticity of epithelial cells

Ludwig Oxford researchers have discovered a key mechanism that governs how cells of the epithelia, the soft lining of inner body cavities, shift between a rigid, highly structured and immobile state and a flexible and motile form.

27 Oct 2014

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Vancive Medical Technologies and Aspen Medical Europe Ltd. today announced an agreement for the exclusive distribution of the Vancive BeneHold Absorbent Wound Dressing portfolio in the United Kingdom and Ireland.

25 Oct 2014

MMP-3 disrupts brain/spinal cord barrier, promotes hemorrhage

Traumatic spinal cord injury (SCI) is a devastating condition with few treatment options. Studies show that damage to the barrier separating blood from the spinal cord can contribute to the neurologic deficits that arise secondary to the initial trauma. Through a series of sophisticated experiments, researchers reporting in The American Journal of Pathology suggest that matrix metalloproteinase-3 (MMP-3) plays a pivotal role in disruption of the brain/spinal cord barrier (BSCB), cell death, and functional deficits after SCI.

20 Oct 2014

Transcutaneous oximetry test may help predict surgical wound-healing complications

As many as 35 percent of patients who undergo surgery to remove soft tissue sarcomas experience wound-healing complications, due to radiation they receive before surgery.

16 Oct 2014

Cytomedix's AutoloGel chronic wound care system re-launched under Aurix brand

Cytomedix, a pioneer in biodynamic therapies, today announced that it has re-launched its AutoloGel chronic wound care system under the Aurix brand. The formal launch of Aurix is an integral part of the Company’s full scale marketing plan for the commercialization of Aurix in the multi-billion dollar U.S. chronic wound care market.

15 Oct 2014

MiMedx announces record revenue results for Q3 2014, issues updated guidance

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today record revenue results for the third quarter of 2014 and issued updated guidance.

13 Oct 2014

Wound News and Research

Scientists use TPF-SHG microscopy to study effects of micro-ablative fractional laser resurfacing

Platelet-like nanoparticles mimic human body's coagulation process

University of Melbourne researcher explores impact of living with chronic wounds

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Stradis Healthcare signs definitive agreement to acquire Medikmark

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Rice-led research shows how migratory cancer cells acquire 'stem-like' properties

Stem cell technologies market expected to show annual increase of 16.2% over 2010-2020

Two major studies newly implicate dozens of genes in autism

Surgeons fine-tune imaging techniques to enhance visualization of breast tumors, persistent wounds

MiMedx Group revenue up 108% in third quarter 2014

Robotically assisted CABG surgery reduces complications, cuts recovery times

AHI develops TRUHEAL Wound Program for diabetics

Ludwig researchers discover key mechanism that control plasticity of epithelial cells

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

MMP-3 disrupts brain/spinal cord barrier, promotes hemorrhage

Transcutaneous oximetry test may help predict surgical wound-healing complications

Cytomedix's AutoloGel chronic wound care system re-launched under Aurix brand

MiMedx announces record revenue results for Q3 2014, issues updated guidance

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News